Follow Sister Wood to lay out the future! ARKK Investment Diagram Reveals Who Has The Most Explosive Potential?

With the rapid development of AI, the technological explosion singularity is approaching at an unprecedented speed.

As a steadfast supporter and bettor of technology innovation, Cathie Wood, the CEO of ARK Invest, known as the 'female version of Buffett,' has made a comeback! $ARK Innovation ETF(ARKK.US)$ This year, it has strongly outperformed those under Buffett. $Berkshire Hathaway-A(BRK.A.US)$ , with an increase of 35% this year.

This year, AI and Cryptos are undoubtedly the hottest investment topics in the Capital Markets.

Looking at the top ten holdings of ARKK, apart from $Tesla(TSLA.US)$ , the first stock of stablecoins $Circle(CRCL.US)$ , the crypto Exchange. $Coinbase(COIN.US)$ 、 $Robinhood(HOOD.US)$ The cumulative rise this year has exceeded 597%, 66%, and 180% respectively; AI application software such as $Roblox(RBLX.US)$ 、 $Palantir(PLTR.US)$ 、 $Shopify(SHOP.US)$ The increases respectively reached 115.17%, 100.7%, and 20.78%; AI Medical Concept stocks $CRISPR Therapeutics(CRSP.US)$ 、 $Tempus AI(TEM.US)$ In the year, the respective rises exceeded 65.98% and 71.83%.

Cathie Wood's latest investment strategy has been revealed! A comprehensive deployment in AI, Cryptos, and more.

Where should investors look to strike gold in the AI era?

In a recent episode of "The Diary of a CEO", Cathie Wood had an in-depth conversation with the well-known host Steven Bartlett, making bold predictions about the technology investment landscape for the next 5 to 10 years.

Cathie Wood proposed five major innovation platforms, including Artificial Intelligence, Robotics, Energy Storage, Blockchain Technology, and Multi-Omics Sequencing. These are not isolated but form a powerful collaborative network through technological integration, and their cumulative effect is reshaping the global industrial landscape.

In fact, 'Cathie Wood' firmly believes that many of the major companies she holds will be the main beneficiaries of the AI boom, including Tesla, among others. From Cathie Wood's latest investment landscape, it can be seen that she is heavily betting on AI applications, AI Medical, Cryptos, and Space Defense.

Specifically:

The largest AI project on Earth - Tesla.

From Cathie Wood's Hold Positions, $Tesla(TSLA.US)$ it is her largest holding stock, which recently declared that 'Tesla is the largest AI project on Earth.'

Wood Sister stated that Tesla's target price in five years is $2600, and 90% of this valuation is driven not by its current electric vehicle business but by its Robotaxi. Wood Sister believes that the market's common perception of Tesla is still at the level of an "electric vehicle company," which represents a significant expectation gap.

Wood Sister particularly emphasized the disruptive potential of the Robotaxi network: this business is expected to generate annual revenue of $8-10 trillion, equivalent to 7% of global GDP. ARK's research predicts that by 2030, Robotaxi will occupy 60% of the global taxi and online car-hailing market.

However, Tesla's grand narrative goes far beyond Robotaxi. Its humanoid robot business, which is being developed, is seen as a potentially even greater growth engine. The key is that humanoid robots share the same core technology platform with Robotaxi: robotics technology, energy storage (batteries), and artificial intelligence. Tesla has established a significant leading advantage in these areas.

Wood Sister stated that the current target price of $2600 does not include the value of humanoid robots, but she predicts that the global humanoid robot market size may eventually reach an astonishing $26 trillion, and its long-term potential may even surpass the Robotaxi business.

Elon Musk has also candidly stated that the humanoid robot business is expected to surpass autonomous driving and become Tesla's largest growth point in the future.

It is worth noting that the robotics and autonomous driving fields are also the two areas most favored by NVIDIA CEO Jensen Huang, and interested mooers can click to view."Jensen Huang Defines the New Wave of AI! Physical AI May Open a Great Era, Which Two Industries Are Expected to Take Off?"。

In the field of Cryptos, Bitcoin is expected to reach 1.5 million dollars.

Ark's CEO has always stated that Bitcoin is still in a bull market stage, and the price will reach 1.5 million dollars before 2030. It is believed that Bitcoin will not only be an asset but also a rule-driven global currency.

In fact, this year, the Cryptos field has become the focus of market attention. In addition to Bitcoin breaking the 0.12 million dollar milestone, crypto-related concept stocks have also risen strongly, becoming a direction for speculation in the Capital Markets.

Ark's ARKK holds the first stablecoin stock Circle, the crypto exchange Coinbase, and Robinhood. Additionally, financial technology company Sofi Technologies, which it holds, recently plans to restart Bitcoin and Ethereum trading, and will also launch blockchain-based cross-border remittance services; in the future, it will further expand into stablecoin trading, provide lending services backed by Cryptos, expand payment options, and introduce new staking features.

Moreover, the stablecoin has always been a hot topic in the Hong Kong and U.S. stock markets. Previously, a global Industry Chain panorama was compiled, interested mooers can click to view!

In addition, latest data shows that Ark's CEO bought about 4 million shares overnight. $Bitmine Immersion Technologies(BMNR.US)$ The amount spent reached 0.19 billion dollars. It is worth noting that Palantir's founder Peter Thiel also holds about 9.1% of BMNR shares.

In fact, this year, from Finance to Technology, from Medical to Entertainment, more and more listed companies are following the strategy path, incorporating crypto assets such as BTC, ETH, SOL, and TRX into their balance sheets, starting a capital game of revaluation. Ark's bet on BMNR is also part of a company that holds Ethereum.

PreviouslyTrump makes a bold move! 9 trillion pension funds may flow into the crypto market, which of these concept stocks are expected to explode?、Ethereum reserves become a new trend in the market! Which publicly listed companies holding coins are worth betting on?An article has previously outlined the coin-holding stocks in the US stock market and the logic behind them, interested mooers can click to see.

The most profound application of AI - the Medical and Health field.

"AI is curing diseases that could not be cured before."

Cathie Wood stated in a recent interview that the most profound applications of AI will emerge in the Medical and Health field.

Because of AI, we have begun to diagnose cancer at the first stage through a single blood test. Think about it, what does this mean? It means that AI can save the lives of most people.

Specifically, in the Medical field, AI can rewrite the underlying logic of disease treatment, enhance the efficiency of drug development, and promote the commercialization of multi-omics sequencing, among other things.

Looking at the AI Medical stocks held by mueler, they cover sub-fields such as gene editing, precision medicine, drug development, and diagnostic testing:

1. Gene Editing and Gene Therapy

$CRISPR Therapeutics(CRSP.US)$ : Genetic editing therapy for hereditary diseases (such as thalassemia, sickle cell anemia). This company has developed a therapy that can cure sickle cell disease and β-thalassemia with a single treatment. Patients with these two diseases used to need to visit the emergency room 10 to 20 times a year for blood transfusions to sustain their lives. Now, they have the opportunity to live a normal life.

$Beam Therapeutics(BEAM.US)$ : Base editing technology (single base modification) for treating hereditary diseases (such as hereditary liver disease and blood disorders). Unlike traditional CRISPR cutting, the base editing technology adopted by Beam replaces only a single base on DNA, avoiding double-strand breaks, with fewer side effects, making it suitable for gene repair of chronic diseases with single-point mutations.

$Intellia Therapeutics(NTLA.US)$ : In vivo gene editing (delivering CRISPR components through lipid nanoparticles (LNP) to directly repair defective genes in the patient’s body).

2. Synthetic Biology and DNA Design (AI-driven Biomanufacturing)

$Twist Bioscience(TWST.US)$ Twist provides a core tool platform for synthetic biology, offering high-throughput DNA synthesis services to pharmaceutical companies, research institutions, diagnostic companies, and others, providing standardized, scalable "molecular building blocks." It does not directly develop drugs but focuses on how to quickly manufacture "designed molecules," becoming a supplier of underlying components for biological experiments.

3. Precision Medicine

$Tempus AI(TEM.US)$ It is a precision medicine platform. Its core mission is to accelerate the development of precision medicine by utilizing AI and one of the largest clinical and molecular databases in the world. The company helps doctors and researchers provide more accurate diagnoses, more personalized treatment plans for cancer and other complex disease patients through gene sequencing, medical data analysis, and AI platforms, and accelerates the development of new drugs and clinical trial processes, striving to improve patient treatment outcomes.

$10x Genomics(TXG.US)$ It is a leading life science technology company dedicated to developing innovative tools for single-cell analysis and spatial multi-omics analysis.

4. Drug Development

$Recursion Pharmaceuticals(RXRX.US)$ It is a biotechnology company committed to accelerating drug discovery and development through large-scale automated experiments and AI, with a core approach of generating and analyzing vast biological and chemical datasets to discover new disease biological mechanisms and potential therapeutic molecules.

5. Gene Sequencing and Data Analysis

$Illumina(ILMN.US)$ It focuses on the development and supply of gene sequencing equipment. The recently launched new tool PromoterAI can assist in identifying regulatory variants in non-coding regions, helping to improve the diagnosis efficiency of rare diseases.

6. Tumor liquid biopsy (AI analysis of circulating tumor DNA/markers)

$Guardant Health(GH.US)$ : Tumor liquid biopsy + multi-cancer early screening, which is promoting the shift in cancer screening methods from the traditional colonoscopy to more acceptable blood tests.

$Natera(NTRA.US)$ : Non-invasive prenatal testing (NIPT) and cancer postoperative recurrence monitoring (MRD). This is a diagnostic company focused on circulating free DNA (cfDNA) testing, covering oncology, women's health, and organ transplantation. In women's health, Panorama offers non-invasive prenatal testing, while Horizon conducts carrier screening.

In the field of oncology, Signatera is a personalized, tumor-informed minimal residual disease (MRD) testing product used for monitoring cancer recurrence and treatment response. Additionally, Prospera is used to assess the risk of organ transplant rejection.

$Veracyte(VCYT.US)$ : This company's products are used to enhance the diagnostic accuracy of diseases such as cancer, covering various clinical scenarios including thyroid cancer, prostate cancer, and breast cancer. The common feature of these products is that they do not rely on tissue morphology judgment but rather analyze RNA expression patterns to determine whether there is abnormal cellular activity.

Additionally, Wood Sister has also placed bets on genetic sequencing companies $Pacific Biosciences of California(PACB.US)$ , medical devices. $Cerus(CERS.US)$

To learn more about AI Medical companies, click to view.《'AI + Medical' is supported by Pelosi and ARK Invest, Bullish on it! Besides Tempus AI, what other investment opportunities are there in this field?》。

Heavy holdings in the AI application layer, not the chip layer?

Despite ARK Invest holding chip stocks. $Advanced Micro Devices(AMD.US)$ 、 $Taiwan Semiconductor(TSM.US)$ 、 $NVIDIA(NVDA.US)$ 、 $Teradyne(TER.US)$ 。

However, most of the stocks that Wood Sister has in her Hold Positions are bets on AI application software stocks, such as $Palantir(PLTR.US)$ 、 $Roblox(RBLX.US)$ 、 $Shopify(SHOP.US)$ 、 $Amazon(AMZN.US)$ 、 $DraftKings(DKNG.US)$ 、 $PagerDuty(PD.US)$ 、 $Meta Platforms(META.US)$ 、 $Gitlab(GTLB.US)$ 、 $The Trade Desk(TTD.US)$ 、 $Pinterest(PINS.US)$ 、 $Airbnb(ABNB.US)$ 。

In addition, to learn more about AI application stocks, click to view.Under the impact of DeepSeek, who will be the winner? These U.S. stocks are expected to usher in the 'golden era'!

Space & Defense & Drones

Artificial intelligence will also deeply penetrate the defense and space sectors, for example, by using autonomous drones to ensure the safety of soldiers.

Wooden Sister has placed a bet on providing mobile communication services through low Earth orbit Satellites. $Iridium Communications(IRDM.US)$ , American defense technology companies $Kratos Defense & Security Solutions(KTOS.US)$ , and leaders in the EVTOL (flying cars) sector $Archer Aviation(ACHR.US)$ . Archer Aviation not only has strong prospects in the electric vertical take-off and landing vehicle (eVTOL) sector but is also gradually penetrating the AI field of the U.S. military.

In addition to the aforementioned industries, Wooden Sister also holds positions in agriculture + Robotics, nuclear power companies $Deere(DE.US)$ $BWX Technologies(BWXT.US)$ , and streaming media. $Roku Inc(ROKU.US)$ CNI Xiangmi Lake Fintech Index $Block(XYZ.US)$ And so on.

At this moment, in the next 5-10 years, AI may change various fields. Cathie Wood repeatedly emphasizes: understand these new technologies and seize the opportunities this era presents. The initiative is in your own hands. Mooers, are you ready?